Effects of maternal cigarette smoke exposure on renal and other health outcomes in mice offspring by Al-Odat, Ibrahim
  
Effects of Maternal Cigarette Smoke Exposure 




A thesis submitted in fulfilment of the requirements 









Faculty of Science 
 











Certificate of original authorship 
 
 
I certify that the work in this thesis has not previously been submitted for a 
degree nor has it been submitted as part of requirements for a degree except as 
fully acknowledged within the text. 
 
I also certify that the thesis has been written by me. Any help that I have 
received in my research work and the preparation of the thesis itself has been 
acknowledged.  
 
In addition, I certify that all information sources and literature used are indicated 
in the thesis. 
 
 




























First and foremost, I would like express my deep and sincere gratitude to my principle 
supervisor, Dr. Hui Chen for giving me the opportunity to pursue my postgraduate study 
under her supervision. I would like to thank her for the project which I really have 
enjoyed. I would like to thank her for the guidance and patience. I had great opportunity 
and privileges to be involved in the work she does. 
At the same level of acknowledgment, I owe an immense debt of gratitude and 
appreciation to my co-supervisor Dr. Sonia Saad, from the Renal Research Group at the 
Kolling Institute of Medical Research for her intellectual and technical supports, 
guidance and above all, her kindness. Without her mentoring, it would be impossible for 
me to make it through.  
Utmost gratitude is to Professor Carol Pollock, the head of the Renal Research Lab at 
the Kolling Institute, and Associate Professor Stella Valenzuela, from the School of Life 
Sciences at UTS, who have been involved in my supervision for the constructive and 
valuable comments, directions and wisdom.  
I would like to thank my colleagues at School of Life Sciences, in particular Heba Al-
khamici, Yik Lung (Jeremy) Chan and Jane NG. I also like to thank Ms Fiona Read and 
Ms Lalit Overlunde at Ernest Animal Facility at UTS for their assistance with the 
animal maintenance in this project. I’d also like to thank Dr Amgad Sawiris at the 
Kolling Institute for his contribution to the kidney histological experiments.  
I would like to thank the Renal Lab manager at the Kolling Institute, Dr. Xin-Ming 
Chen, post-Doctoral fellows, Drs. Usha Panchapakesan, Muh-Geot Wong, Helen 
Huang, and all the other PhD students and research assistants in the Renal Research Lab 
at the Kolling Institute for the friendly atmosphere which made the laboratory work 
enjoyable. I also like to thank Dr. Sergey Kurdyukov, the manager of the Genomic Core 
Facility and Ms Susan Smith from the Histology Lab at the Kolling Institute for their 
technical supports.  
I would like to thank everyone in the School of Life Sciences at the UTS who had a 







I would like to acknowledge my financial supporters during my PhD candidature; the 
Australian Department of Education and Training for the Australian Postgraduate 
Award, and the Faculty of Science and Graduate Research School at UTS for the travel 
awards. Their financial support greatly aided me in completing my PhD. 
Last but not least, I am unlimitedly grateful to my father, my sister, my brothers, and my 
in-laws for their constant encouragement, moral support and for having faith in me.  My 
greatest gratitude goes to my lady who has been supportive during this stage of my life. 
Her patience and caring were remarkable. Thanks to my kids, Hala and Aws, whose 























Table of Contents 
 
Page 
Certificate of original authorship……………………………………………… i 
Dedication……………………………………………………………………… ii 
Acknowledgements……………………………………………………………. iii 
Table of Contents……………………………………………………………… v 
List of Figures……………………………………………………………………….. xii 
List of Tables………………………………………………………………… xiv 
List of Abbreviations………………………………………………………… xvi 
List of peer reviewed Publications…………………………………………. xix 
List of conference abstracts…………………………………………………. xix 
     Oral presentations………………………………………………………… xix 
     Poster presentations………………………………………………………… xx 
Awards………………………………………………………………………… xxi 
Abstract………………………………………………………………………… xxii 
1. Chapter One: General introduction and literature review 
 
 
1.1. General introduction………………………………………………………. 2 
1.2. The kidney………………………………………………………………… 3 
1.2.1. Background……………………………………………………………... 3 
1.2.2. Kidney morphogenesis…………………………………………………. 5 
1.2.3. Growth and transcriptional factors in early kidney development……… 8 
1.2.4. Risk factors for kidney disease…………………………………………. 10 
1.2.4.1. Biomedical factors……………………………………………………. 10 
1.2.4.2. Fixed factors………………………………………………………….. 12 





1.2.4.4. Intrauterine environmental factors……………………………………. 14 
1.2.4.4.1. Maternal malnutrition………………………………………………. 14 
1.2.4.4.2. Gestational diabetes………………………………………………… 15 
1.2.5. Gender differences in renal pathophysiology…………………………… 17 
1.2.5.1. Fibrogenic and inflammatory factors………………………………… 17 
1.2.5.2. NO……………………………………………………………………. 18 
1.2.5.3. ET-1…………………………………………………………………… 19 
1.2.5.4. RAS…………………………………………………………………… 19 
1.2.6. Aetiology of kidney disease…………………………………………...... 20 
1.2.7. Signs and symptoms of kidney disease………………………………… 21 
1.2.8. Diagnosis of kidney disease…………………………………………….. 21 
1.2.9. Complications and prognosis…………………………………………… 22 
1.2.10. Treatment and management……………………………………………. 22 
1.3. The developmental origins of adult health and disease…………………… 23 
1.3.1. Mechanisms for the developmental programming of adulthood diseases. 24 
1.3.1.1. Oxidative stress……………………………………………………….. 24 
1.3.1.2. Apoptosis…………………………………………………………….. 25 
1.3.1.3. Epigenetic modifications…………………………………………….. 26 
1.3.1.4. Gender specific programming……………………………………….. 26 
1.4. The developmental programming of adulthood kidney disease………… 28 
1.5. Maternal cigarette SE and its consequences……………………………… 29 
1.5.1. Smoking as a global public health problem……………………………. 29 
1.5.2. Organ damage by chemicals in the cigarette smoke…………………… 30 
1.5.3. Adverse impact of maternal smoking………………………………….. 31 
1.5.3.1. Short term consequences……………………………………………… 31 





1.6. Carnitine…………………………………………………………………... 35 
1.6.1. Background……………………………………………………………… 35 
1.6.2. Carnitine deficiency…………………………………………………….. 36 
1.6.3. Carnitine and the kidney………………………………………………… 37 
1.6.4. Carnitine and Liver fatty acids metabolism…………………………….. 37 
1.7. Significance, hypotheses and aims……………………………………….. 38 
 
2. Chapter Two: Materials and Methods 
 
 
2.1. Animal experiment………………………………………………………. 41 
2.1.1. Ethics approval…………………………………………………….…… 41 
2.1.2. Animal model and tobacco cigarette smoke exposure…………………. 41 
2.1.3. Intraperitoneal glucose tolerance test (IPGTT)………………………… 42 
2.1.4. Tissues collection………………………………………………………... 42 
2.2. Real-time PCR……………………………………………………………. 43 
2.2.1. Total RNA extraction…………………………………………………… 43 
2.2.2. First strand cDNA synthesis…………………………………………….. 44 
2.2.3. Quantitative real-time PCR (qPCR)…………………………………….. 46 
2.3. Kidney histology, glomerular number and size measurement……………. 52 
2.3.1. H&E staining……………………………………………………………. 52 
2.3.2. PAS staining……………………………………………………………. 52 
2.3.3. Masson’s staining……………………………………………………….. 53 
2.4. Immunohistochemistry staining…………………………………………. 54 
2.5. ELISA……………………………………………………………………. 55 
2.5.1. Urinary albumin assay………………………………………………….. 55 
2.5.2. Urinary creatinine assay………………………………………………… 56 





2.5.4. Plasma cotinine assay………………………………………………….. 57 
2.6. Serum enzymatic creatinine……………………………………………… 58 
2.7. Plasma non-esterified fatty acids (NEFA ) assay………………………… 58 
2.8. Plasma TG assay…………………………………………………………. 58 
2.9. Statistical analysis………………………………………………………… 58 
 
3. Chapter Three: The Impact of Maternal Cigarette Smoke Exposure on 





3.1. Introduction………………………………………………………………... 61 
3.2. Materials and methods…………………………………………………….. 62 
3.2.1. Modelling cigarette smoke exposure in mice…………………………… 62 
3.2.2. Tissues collection………………………………………………………... 63 
3.2.3. IPGTT…………………………………………………………………… 63 
3.2.4. Real-time PCR………………………………………………………….. 63 
3.2.5. Kidney histology and IHC staining……………………………………. 65 
3.2.6. Glomerular number and size measurement…………………………… 66 
3.2.7. Albumin and creatinine assays…………………………………………. 66 
3.2.8. Statistical analysis………………………………………………………. 66 
3.3. Results……………………………………………………………………. 66 
3.3.1. Female breeders………………………………………………………… 66 
3.3.2. Parameters in the offspring……………………………………………… 67 
3.3.2.1 Kidney histological changes and glomerular numbers………………… 69 
3.3.2.2 Kidney mRNA and protein levels…………………………………….. 74 
3.3.2.3 Renal markers of inflammation, injury and function…………………. 80 






4. Chapter Four: Impact of Maternal Cigarette Smoke Exposure on 
Renal Pathophysiology in the Female Offspring 
 
 
4.1. Introduction……………………………………………………………….. 89 
4.2. Materials and methods………………………………………………….... 91 
4.2.1. Animal model and cigarette smoke exposure protocol………………… 91 
4.2.2. IPGTT…………………………………………………………………… 91 
4.2.3. Tissues collection………………………………………………………. 91 
4.2.4. Real-time PCR………………………………………………………….. 92 
4.2.5. Kidney histology and IHC staining……………………………………. 92 
4.2.6. Albumin and creatinine assays………………………………………… 94 
4.2.7. Cotinine assay………………………………………………………….. 94 
4.2.8. Statistical analysis………………………………………………………. 94 
4.3. Results…………………………………………………………………….. 95 
4.3.1. Body parameters of the offspring……………………………………… 95 
4.3.2. Kidney histological changes in the offspring………………………….. 96 
4.3.3. Kidney mRNA and protein levels of growth and transcription factors… 99 
4.3.4. Renal markers of injury, inflammation and function in the offspring…. 104 
4.3.5. IPGTT…………………………………………………………………… 106 
4.4. Discussion…………………………………………………………………. 108 
 
5. Chapter Five: The Effects of Maternal L-Carnitine Supplementation 
on Ameliorating Renal Underdevelopment and Dysfunction, and Glucose 




5.1. Introduction……………………………………………………………….. 114 
5.2. Methodology……………………………………………………………… 115 
5.2.1. Animal model and tobacco cigarette smoke exposure protocol………… 115 





5.2.3. Tissues collection……………………………………………………….. 116 
5.2.4. Real-time PCR………………………………………………………….. 116 
5.2.5. Kidney histology and IHC staining…………………………………….. 117 
5.2.6. ELISA………………………………………………………………….. 118 
5.2.7. Serum enzymatic creatinine……………………………………………. 118 
5.2.8. Statistical analysis……………………………………………………… 119 
5.3. Results…………………………………………………………………….. 119 
5.3.1. Developmental parameters of the male mice offspring………………. 119 
5.3.2. Renal histological changes…………………………………………… 121 
5.3.3. mRNA and protein expression of renal growth and transcription 
factors…………………………………………………………………………. 
124 
5.3.4. Renal markers of inflammation, injury and function………………… 130 
5.3.5. IPGTT………………………………………………………………… 133 
5.4. Discussion…………………………………………………………………. 134 
 
6. Chapter Six: The Effects of Maternal L-Carnitine Supplementation on 
Glucose Intolerance and Liver Profile in the Female Mice Offspring of 




6.1. Introduction……………………………………………………………… 139 
6.2. Methodology…………………………………………………………….. 140 
6.2.1. Animal model………………………………………………………….. 140 
6.2.2. IPGTT………………………………………………………………….. 141 
6.2.3. Tissues collection……………………………………………………….. 141 
6.2.4. Real-time PCR………………………………………………………….. 141 
6.2.5. ELISA…………………………………………………………………… 144 
6.2.6. Statistical analysis……………………………………………………….. 144 





6.3.1. Body and liver weights of the female mice offspring………………….. 145 
6.3.2. IPGTT………………………………………………………………….. 146 
6.3.3. mRNA expression of the Inflammatory markers in the liver…………. 147 
6.3.4. mRNA expression of Lipid metabolic markers in the liver……………. 150 
6.3.5. Plasma TG and NEFA levels…………………………………………… 153 
6.4. Discussion……………………………………………………………….… 154 
 
7. Chapter Seven: General Discussion and Perspectives 
 
 
7.1. General discussion………………………………………………………… 161 
7.2. Perspectives……………………………………………………………….. 166 









List of Figures Page 
Figure 1.1: Kidney and nephron anatomy…………………………………… 4 
Figure 1.2: kidney development and morphogenesis in mammals…………….. 7 
Figure 1.3: Risk factors for CKD……………………………………………… 16 
Figure 1.4: Flow chart of maternal cigarette smoking during pregnancy and 
adverse health consequences in offspring……………………………………… 
 
34 




Figure 2.2: Sample of reaction curve using SYBR Green primers…………….. 49 
Figure 2.3: Sample of melting curve showing primers specificity…………… 50 
Figure 2.4: Reaction curve using Taqman probes…………………………… 51 
Figure 2.5: A sample standard curve used to calculate creatinine concentration 
in the urine…………………………………………………………………… 
 
56 
Figure 3.1. Glucose tolerance test in offspring of SE dams at Week 12………. 69 
Figure 3.2. Glomerular number in offspring of SE dams……………………… 70 
Figure 3.3. Kidney PAS staining showing glomerular size in the offspring… 71 
Figure 3.4: PAS stain and Masson’s stain in the kidney from the offspring… 73 




















Figure 3.9. Kidney injury markers expression in offspring mice at W13…… 80 




Figure 4.2: Kidney PAS stained sections from the sham and SE offspring…… 98 
Figure 4.3: Renal mRNA expression of growth and transcription factors in the 
female offspring mice………………………………………………………… 
 
100 








Figure 4.6: Renal pax2 protein expression in the female offspring mice……… 103 
Figure 4.7: Renal mRNA expression of injury markers fibronectin , colagen 
IV and MCP-1 in the female offspring at W13………………………………... 
 
104 
Figure 4.8: Renal fibtonectin and collagen IV protein expression in the Sham 
and SE offspring at W13……………………………………………………… 
 
105 
Figure 4.9: IPGTT results in the female offspring mice at 12 weeks………… 107 
Figure 5.1: H&E stained kidney sections from offspring showing the number 
of developed glomeruli in the male offspring………………………………… 
 
122 




Figure 5.3: mRNA expression of renal growth and transcription factors in the 
male offspring mice…………………………………………………………… 
 
125 





Figure 5.5: Renal GDNF protein expression in the male offspring…………… 128 
Figure 5.6: Renal Pax2 protein expression in the male offspring……………… 129 
Figure 5.7: Renal mRNA expression of fibronectin, collagen IV and MCP-1 
in the male offspring at W13………………………………………………… 
 
131 
Figure 5.8: IPGTT results in the male offspring mice at 12 weeks…………… 133 
Figure 6.1: IPGTT and plasma insulin level in the female offspring mice……. 146 
Figure 6.2: Hepatic mRNA expression of inflammatory markers at p20……… 148 
Figure 6.3: Hepatic mRNA expression of inflammatory markers at W13…… 149 
Figure 6.4: Hepatic mRNA expression of lipid metabolic markers at   P20… 151 
Figure 6.5: Hepatic mRNA expression of lipid metabolic markers at W13…… 152 
 
List of Tables 
 
Table 2.1: Forward and reverse sequences of the mice primers for SYBR 
GREEN rt-   PCR……………………………………………………………… 
 
48 
Table 3.1: The effects of smoking on female breeders………………………… 67 
Table 3.2: The effects of maternal smoke exposure on growth and 
development in offspring……………………………………………………… 
 
68 








Table 4.2: The effects of maternal SE on renal function in offspring………… 104 








Table 5.2: The effects of maternal smoke exposure on renal function in the 
male mice offspring at W13…………………………………………………… 
 
132 
Table 6.1: probes sequences for Taqman rt-PCR……………………………… 143 
Table 6.2: Body and liver weights of the female offspring…………………… 145 
Table 6.3: Plasma TG and NEFA concentrations in the female offspring  







List of Abbreviations 
ACE   angiotensin-I-converting enzyme  
AT  angiotensin type 
ATGL  adipose triglyceride lipase 
AUC  area under the curve 
BMI  body mass index 
BMP  bone morphogenetic protein  
BW  body weight 
CKD   Chronic kidney disease 
CPT  carnitine palmitoyl transferase 
DDti3  DNA damage-inducible transcript 3 
E  embryonic day 
ECM  extracellular matrix protein 
eNOS  Endothelial nitric oxide synthase 
ET  endothelin 
Eya1  eyes absent 1 
FASN  Fatty acid synthase  
FGF  Fibroblast growth factor 
FOXO  forkhead box protein O 
GDNF  glial-cell line-derived neurotrophic factor 
GFR  Glomerular Filtration Rate 
GFRα 1 GDNF-family receptor α 1 
Glut  Glucose transporter 
h  hour 
H&E  hematoxylin and eosin 
HRP  horse radish peroxidase 
HSL  hormone-sensitive lipase 
IHC  immunohistochemistry 
i.p  intraperitoneally 
IPGTT  Intraperitoneal glucose tolerance test 
IGF  Insulin-like growth factor 
IL  interleukin 





IUGR  intrauterine growth retardation 
LBW   low birth weight 
LC  L-Carnitine 
LIF  leukaemia inhibiting factor 
mA  milliAmpere 
MCP  monocyte chemoatractant protein 
MM metanephric mesenchyma 
MSA  murine serum albumin 
NC  nephrogenic cord  
NEFA  non-esterified fatty acids 
NHEBSA  normal horse serum with bovine serum albumin 
NFκB nuclear factor kappa B 
NO nitric oxide 
NOS NO synthase 
Pax  paired box transcription factor 
PGC  Peroxisome proliferator-activated receptor gamma coactivator 
P  postnatal day 
PAS  periodic acid Schiff 
PPAR  peroxisome proliferator-activated receptor 
RAS  renin-angiotensin system  
RCF  relative centrifuge force 
RET   receptor tyrosine kinase 
ROS  reactive oxygen species 
RV  renal vesicle 
SE  smoke exposure 
SEM  standard error of the mean 
TG  triglyceride 
TGF-β  transforming growth factor-β  
TLR  Toll-like receptor 
TMB  Tetramethylbenzidine 
TNFα  tumour necrosis factor α 
T-TBS  tween twenty trise buffer saline 





UV  ultra violet 
W13  week 13 
WNT    wingless–type MMTV integration site family member  
Wt1  Wilms tumor 1 







List of peer reviewed Publications 
x Al-Odat I, Chen H, Chan Y-L, Sawiris A. Wong MG, Gill A, Pollock C, Saad S, 
(2014). The impact of maternal cigarette smoke exposure in a rodent model on renal 
development in the offspring. PLoS ONE 9(7): e103443. 
 
x Stangenberg, S., Nguyen, L.T., Chen, H., Al-Odat, I., Killingsworth, M.C., Gosnell, 
M.E., Anwer, A.G., Goldys, E.M., Pollock, C.A. & Saad, S. 2015, 'Oxidative stress, 
mitochondrial perturbations and fetal programming of renal disease induced by 
maternal smoking', The International Journal of Biochemistry & Cell Biology, vol. 
64, pp. 81-90. 
 
x Nguyen, L.T., Stangenberg, S., Chen, H., Al-Odat, I., Chan, Y.L., Gos-nell, M.E., 
Anwer, A.G., Goldys, E.M., Pollock, C.A. & Saad, S. 2015, 'L carnitine reverses 
maternal cigarette smoke exposure induced renal oxidative stress and mitochondrial 
dysfunction in mouse offspring ', Journal of Renal Physiology, vol. 308, no. 7, pp. 
F689-F96. 
 
x Chen, H., Al-Odat, I., Pollock, C. & Saad, S. 2013, 'Fetal programming of renal 
development–influence of maternal smoking', Journal of Diabetes and Metabolism 
S9: 003. 
 
List of conference abstracts 
Oral presentations 
 
x Ibrahim Al-Odat, Hui Chen, Carol Pollock and Sonia Saad. Female mice 
offspring are more susceptible to kidney underdevelopment and decline in kidney 
function than male offspring due to maternal cigarette smoke exposure during 
gestation and lactation. The 49th Annual Scientific Meeting of the Australian and 








x Ibrahim Al-Odat, Hui Chen, Amgad Zaky, Carol Pollock and Sonia Saad, 
Maternal L-Carnitine Supplementation Reversed Kidney Underdevelopment and 
Adulthood Renal Dysfunction in Male Mice Offspring of Cigarette Smoke 
Exposed Dams. New Horizons Conference 2015, University of Technology 
Sydney, Sydney. 
x Ibrahim Al-Odat, Hui Chen, Yik Lung Chan, Carol Pollock and Sonia Saad 
The prophylactic effect of l-carnitine against glucose intolerance and metabolic 
disorders induced by maternal smoke exposure in female offspring mice. The 
51th Annual Scientific Meeting of the Australian and New Zealand Society of 
Nephrology, 2015. Canberra, ACT, Australia. 
 
x Ibrahim Al-Odat, Hui Chen, Yik Lung Chan, Amgad Sawiris, Carol Pollock 
and Sonia Saad. The effect of maternal cigarette smoke exposure on offspring 
predisposition to kidney disease in male and female mice. The American Society 
of Nephrology annual meeting, 2014, Philadelphia, PA, USA. 
x Ibrahim Al-Odat, Hui Chen, Amgad Sawiris, Carol Pollock and Sonia Saad. l-
carnitine supplementation during gestation and lactation improve glucose 
intolerance induced by maternal smoking in the offspring. The 50th Annual 
Scientific Meeting of the Australian and New Zealand Society of Nephrology, 
2014. Melbourne, Victoria, Australia 
x Al-Odat, Ibrahim, Chen, Hui, Chan, Yik Lung, Sawaris, Amgad, Pollock, 
Carol and Saad, Sonia. Gender related differences in susceptibility to kidney 
disease in the mice offspring due to maternal cigarette smoke exposure. New 
Horizons Conference 2014, Kolling Institute of Medical Research, Sydney.  
x Ibrahim Al-Odat, Sonia Saad, Carol Pollock and Hui Chen. Maternal smoking 
as an intrauterine factor to disturb fetal renal development and cause renal 








x Thesis Completion Equity Grant, 2015. 
x Australian Postgraduate Award (APA). 
x UTS Vice-Chancellor’s Postgraduate Research Student International Conference 
Fund Award, 2013, 2014. 
x Faculty of Science/UTS High Degree Research Student International Conference 




























The burden of kidney disease is significantly increased worldwide. Developmental 
programming of non-communicable diseases is an established paradigm. Therefore, 
there is increasing attention to the contribution of intrauterine and early post-natal 
environmental insults to the risk of adulthood kidney diseases. One of such insults is 
maternal cigarette smoke exposure (SE), which is associated with intrauterine growth 
retardation (IUGR) and some adulthood diseases in offspring. However, it is unknown 
whether maternal SE can increase the risk of developing chronic kidney disease (CKD) 
in offspring. Maternal SE was also shown to increase renal oxidative stress in offspring; 
while the anti-oxidants L-carnitine (LC) supplementation has been shown to be 
beneficial in many human diseases, which may benefit such offspring. 
Objectives  
This thesis aimed to study the effect of maternal SE on, 1) kidney development and 
renal function; 2) glucose and lipid metabolic markers in the liver, and; 3) the effect of 
maternal LC supplementation during gestation and lactation on health outcome of the 
SE offspring.  
Methods  
Female Balb/c breeder mice were exposed to cigarette smoke for 6 weeks prior to 
mating, during gestation and lactation; with sham exposure as control. A subgroup of 
the SE dams was treated with LC (SE+L-C) during gestation and lactation via drinking 
water. The offspring were sacrificed at postnatal day (P)1, P20 (weaning age) and 13 
weeks (mature age). Blood, urine, kidneys and livers were collected. Renal Morphology 
and function, renal development factors, and metabolic markers in the liver were 
examined in the offspring.  
Results  
Reduced nephrons number, enlarged glomerular size and altered renal expression of 
developmental factors such as glial cell line-derived neurotrophic factor (GDNF) and 
paired box binding protein (Pax)2 were observed in the offspring. This was linked to 





protein (MCP)-1, and urine albumin/creatinine ratio at adulthood in the male offspring. 
However female offspring were protected from such maternal effect. Both genders 
developed glucose intolerance. mRNA expression of IL-1β and TNF-α was upregulated 
in the liver in the female offspring, with hyperlipidemia. Maternal LC supplementation 
during gestation and lactation ameliorated these changes in the offspring by maternal 
SE. 
Conclusion  
Maternal SE led to kidney underdevelopment, adulthood renal dysfunction, lipid and 
glucose metabolic disorders, and increased renal and liver inflammation in the offspring 
in a gender-specific manner. Maternal LC supplementation has a beneficial role in 
ameliorating the detrimental impact of maternal SE on the offspring. 
 
